Seelenberger Alexander A.'s Form 4 filing
Vincerx Pharma, Inc. (VINC) · filed Aug 14, 2023
- Accession no.
- 0000950170-23-042406
- Filed
- Aug 14, 2023
- Trade date
- Aug 11, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $9.97K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Seelenberger Alexander A.CIK 0001832562 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Common Stock | PPurchaseAcquired | +10,500 | $0.95F1 | +$9,975 | 30,280 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents a weighted average purchase price. Actual purchase prices ranged from $0.9374 to $0.9499 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
Referenced by the price of 1 transaction in Table I.